BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4327743)

  • 21. Clinical and steroid metabolic studies in four siblings with congenital virilizing adrenal hyperplasia.
    Hall K; Hökfelt B
    Acta Endocrinol (Copenh); 1966 Aug; 52(4):535-49. PubMed ID: 4287879
    [No Abstract]   [Full Text] [Related]  

  • 22. Congenital adrenogenital syndrome and successful pregnancy. Report of a case.
    Mori N; Miyakawa I
    Obstet Gynecol; 1970 Mar; 35(3):394-400. PubMed ID: 5461317
    [No Abstract]   [Full Text] [Related]  

  • 23. Quantitative estimation of urinary pregnanetriol, pregnanetriolone, tetrahydro S and delta-5-pregnenetriol in the investigation of adrenocortical function.
    Thomas FJ; Steinbeck AW
    Acta Endocrinol (Copenh); 1969 Apr; 60(4):657-68. PubMed ID: 5819067
    [No Abstract]   [Full Text] [Related]  

  • 24. Androgen production in boys with sexual precocity and congenital adrenal hyperplasia.
    Levine LS; New MI; Pitt P; Peterson RE
    Metabolism; 1972 May; 21(5):457-64. PubMed ID: 4335735
    [No Abstract]   [Full Text] [Related]  

  • 25. Steroid studies in parents of patients with congenital virilizing adrenal hyperplasia.
    Qazi QH; Hill JG; Thompson MW
    J Clin Endocrinol Metab; 1971 Jul; 33(1):23-6. PubMed ID: 5558039
    [No Abstract]   [Full Text] [Related]  

  • 26. Cortisol production rate. V. Congenital virilizing adrenal hyperplasia.
    Migeon CJ; Kenny FM
    J Pediatr; 1966 Nov; 69(5):779-86. PubMed ID: 4288888
    [No Abstract]   [Full Text] [Related]  

  • 27. Dose-response comparison between dexamethasone and 16-methylene-6-dehydrocortisol in the short-term suppression test.
    Gillich KH; Krüskemper HL
    Horm Metab Res; 1970 Mar; 2(2):106-9. PubMed ID: 4329445
    [No Abstract]   [Full Text] [Related]  

  • 28. [A contribution to the therapy of the congenital adrenal hyperplasia (author's transl)].
    Gleispach H
    Wien Klin Wochenschr; 1974 Sep; 86(17):508-11. PubMed ID: 4408420
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pregnantriolon excretion after ACTH-stimulation in possible heterocygotes of 21-hydroxylase deficiency (author's transl)].
    Gleispach H; Berger H; Glatzl J; Rössler H; Tschager E
    Padiatr Padol; 1971; 6(3):287-96. PubMed ID: 4363023
    [No Abstract]   [Full Text] [Related]  

  • 30. Deficient 17-hydroxylation in a corticosterone producing adrenal tumor from an infant with hemihypertrophy and visceromegaly.
    Weinstein RL; Kliman B; Neeman J; Cohen RB
    J Clin Endocrinol Metab; 1970 Apr; 30(4):457-68. PubMed ID: 4907843
    [No Abstract]   [Full Text] [Related]  

  • 31. Androgen metabolism in congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency.
    Frasier SD; Horton R; Ulstrom RA
    Pediatrics; 1969 Aug; 44(2):201-8. PubMed ID: 5806251
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pregnanetriolone and the adrenogenital syndrome].
    Lohmeyer H
    Bibl Gynaecol; 1970; 53():1-98. PubMed ID: 5437131
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pregnanetriolone excretion after stimulation with ACTH as a test on presumably heterozygous carriers of a 21-hydroxylase-deficiency (author's transl)].
    Gleispach H; Berger H; Glatzl J; Rössler H
    Padiatr Padol; 1974; 9(3):204-8. PubMed ID: 4369650
    [No Abstract]   [Full Text] [Related]  

  • 34. Successful prenatal treatment of congenital adrenal hyperplasia resulting from the 21-hydroxylase deficiency: is prenatal diagnosis in a mother at risk essential?
    Romer TE; Ginalska-Malinowska M
    Endokrynol Pol; 1987; 38(1):125-30. PubMed ID: 3428229
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of menstrual irregularities with dexamethasone in congenital adrenal hyperplasia.
    Granoff AB
    J Adolesc Health Care; 1981 Sep; 2(1):23-7. PubMed ID: 7333940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [17-hydroxyprogesterone in the diagnosis and treatment of adrenogenital syndrome].
    Cassorla F
    Rev Chil Pediatr; 1982; 53(4):295-304. PubMed ID: 7163538
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of ACTH administration on aldosterone production in non salt-losing congenital adrenal hyperplasia.
    Beitins IZ; Bayard F; Kowarski A; Migeon CJ
    J Clin Endocrinol Metab; 1972 Oct; 35(4):595-603. PubMed ID: 4340790
    [No Abstract]   [Full Text] [Related]  

  • 38. Long-term steroid therapy in patients with adrenogenital syndrome.
    Riddick DH; Hammond CB
    Obstet Gynecol; 1975 Jan; 45(1):15-20. PubMed ID: 163015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Congenital adrenal hyperplasia: simultaneous determination of plasma aldosterone and 17-hydroxyprogesterone.
    Parth K; Zimprich H; Swoboda W; Brunel R; Bohrn E
    Acta Endocrinol (Copenh); 1978 Jan; 87(1):148-57. PubMed ID: 202131
    [No Abstract]   [Full Text] [Related]  

  • 40. A case of adrenocortical hyperfunction normalized during the second and third trimesters of three pregnancies.
    Jorgensen PI; Sele V
    Acta Endocrinol (Copenh); 1973 May; 73(1):105-16. PubMed ID: 4740144
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.